DARE-APS: a new clinical trial
DARE-APS, a new clinical trial investigating the safety of the drug Darzalex® (daratumumab) in patients with antiphospholipid syndrome (APS) is now open for enrollment at two study sites.
See https://www.dare-aps.org for more information
Our Mission
Founded in 2005, the APS Foundation of America, Inc. is dedicated to fostering and facilitating joint efforts in the areas of education, public awareness, research, and patient services for Antiphospholipid Syndrome (APS) in an effective and ethical manner.
Information Sheets
DISCLAIMER: The APS Foundation of America, Inc. website is not intended to replace standard doctor-patient visits, physical examination, and medical testing. Information given to members is only an opinion. All information should be confirmed with your doctor. Always seek a trained physician's advice before seeking any new treatment regarding your medical diagnosis or condition. Any information received from the APS Foundation of America, Inc. website is not intended to diagnose, treat, or cure. This site is for informational purposes only. Please note that we will list all donors' or purchasers' names on the donor page of our foundation site. If you do not want your name listed, please get in touch with us to opt-out. If you think you may have a medical emergency, call your doctor or 911 immediately.